Skip to main content
LM

Lunair Medical

This startup is developing a novel, non-invasive therapy for obstructive sleep apnea that aims to restore normal airflow during sleep. Their approach eliminates the need for external devices or oral appliances, offering patients a more comfortable and natural solution for managing their condition.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Obstructive sleep apnea (OSA) is commonly treated with devices like CPAP machines or oral appliances, which can be uncomfortable, cumbersome, and lead to poor patient compliance. Many individuals with OSA do not have effective therapy options or struggle to adhere to existing treatments.

Solution

Lunair Medical is developing a novel therapy designed to restore normal airflow in the upper airway during sleep, addressing the limitations of current OSA treatments. The system aims to work with the body’s natural breathing mechanism to maintain airway stability and patency throughout the night. This approach eliminates the need for externally worn equipment or oral appliances, offering a more seamless and natural integration into sleep. The goal is to provide an effective solution for a broader range of OSA patients, including those who have not found success with existing therapies.

Target Audience

The primary target audience includes individuals diagnosed with obstructive sleep apnea (OSA) who are seeking alternative treatment options to traditional CPAP therapy or oral appliances.

Features

  • Restores normal airflow of the upper airway during sleep.
  • Designed for seamless integration into sleep without external devices or oral appliances.
  • Aims to treat patients who currently do not have effective therapy for their sleep apnea.
This profile is AI-generated and may contain inaccuracies.